Search Results - "Smircic Duvnjak, L"

Therapy of nonalcoholic fatty liver disease: current status by Duvnjak, M, Tomasic, V, Gomercic, M, Smircic Duvnjak, L, Barsic, N, Lerotic, I

“…Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, has become a common entity in clinical practice. In most of the…”
Get more information

Effects of a Fixed Mixture of 25% Insulin Lispro and 75% NPL on Plasma Glucose during and after Moderate Physical Exercise in Patients with Type 2 Diabetes by Herz, M., Profozic, V., Arora, V., Smircic-Duvnjak, L., Kovacevic, I., Boras, J., Campaigne, B. N., Metelko, Z.

“…Summary Objective: To compare the plasma glucose (PG) response with a fixed mixture of 25% insulin lispro and 75% NPL (Mix25), prior to a meal and 3 h before…”
Get full text

Evaluation of glycation gap for clinical use in diabetes management by Krhac, M., Bozicevic, S., Duric, D. Stosic, Juresa, D. Soldo, Duvnjak, L. Smircic, Lovrencic, M. Vucic

Get full text

High-density lipoprotein behaviour, as an adiponectin predictor, implies the risk of type 2 diabetes by Ljubic, S., Piljac, A., Antal, I., Jazbec, A., Smircic duvnjak, L.

Get full text

Adiponectin and high-density lipoprotein are closely related to fatty liver, yet cystatin C emerges as an important factor in the prediction of diabetic nephropathy by Piljac, A., Ljubic, S., Jazbec, A., Vucic lovrencic, M., Smircic duvnjak, L.

Get full text

Diagnostic value of thyrotropin releasing hormone test in 129 patients with suspected tumoral hyperprolactinemia by Smircić-Duvnjak, L, Vizner, B, Korsić, M, Sekso, M, Berković, M

“…In 129 hyperprolactinemic (PRL > or = 100 ng/mL) and 100 normoprolactinemic patients (PRL 0-25 ng/mL), delta max. PRL (the difference between maximal prolactin…”
Get more information

Association of cardiometabolic risk factors with proteinuria in normoalbuminuric diabetic patients by Božičević, S., Krhač, M., Matišić, E., Jureša, D. Soldo, Duvnjak, L. Smirčić, Lovrenčić, M. Vučić

Get full text

Incidence of diabetes mellitus type 2 in the European population chronically exposed to arsenic by Barbir, R., Michalke, B., Lucio, M., Tariba, B., Lovrenčić, M. Vučić, Šerić, V., Canecki-Varžić, S., Ljubić, S., Duvnjak, L. Smirčić, Krivohvalek, A., Vrček, I. Vinković

Get full text

Takayasu's arteritis and chronic autoimmune thyroiditis in a patient with type 1 diabetes mellitus by Bulum, Josko, Car, Nikica, Smircic-Duvnjak, Lea, Gracin, Sonja, Metelko, Zeljko

“…Takayasu's arteritis is a rare, chronic inflammatory disease of unknown origin, affecting the walls of the aorta and its main branches, as well as coronary and…”
Get full text

Tuberculous peritonitis--a case report by Duvnjak, M, Smircić-Duvnjak, L, Simicević, V N, Supanc, V

“…Tuberculosis continues to be a major health problem worldwide and, due to its systemic nature, its clinical presentation may be highly variable. The diagnosis…”
Get more information

Whipple's disease: a case study with unexpected prognosis by Duvnjak, M, Antić, Z, Supanc, V, Simicević, V N, Smircić-Duvnjak, L

“…Due to the systemic nature of Whipple's disease, its clinical presentation may be highly variable. The diagnosis may, therefore, be unduly delayed. Untreated,…”
Get more information

Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography by Duvnjak, M, Supanc, V, Simicević, V N, Hrabar, D, Troskot, B, Smircić-Duvnjak, L, Bekavac-Beslin, M

“…Acute pancreatitis is a serious complication of endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic sphincterectomy (EST). In addition, serum…”
Get more information